METHYLING OF IL6 AND MMP13 GENE PROMOTORS IN PATIENTS WITH METABOLIC SYNDROME AND TYPE 2 DIABETES ON THE BACKGROUND OF CHRONIC PERIODONTITIS

Authors

  • P. D. Rozhko Odessa National Medical University
  • O. V. Denga State Establishment "The Institute of Stomatology and Maxillo-Facial Surgery National Academy of Medical Science of Ukraine"
  • T. G. Verbitskaya State Establishment "The Institute of Stomatology and Maxillo-Facial Surgery National Academy of Medical Science of Ukraine"
  • S. A. Shnaider State Establishment "The Institute of Stomatology and Maxillo-Facial Surgery National Academy of Medical Science of Ukraine"
  • V. V. Bubnov Odessa International Medical University

DOI:

https://doi.org/10.35220/2523-420X/2020.1.13

Keywords:

DNA methylation, IL6 and MMP13 genes, chronic generalized periodontitis, diabetes mellitus, metabolic syndrome

Abstract

In the pathogenesis of periodontitis and its progression, important role belongs to bone resorption mechanisms, which must be taken into account during orthopedic treatment. Inflammatory cytokines and matrix metalloproteinases induce this mechanism. A DNA methylation study was conducted to evaluate the epigenomic variations in the promoters of the IL6 and MMP13 genes in patients with chronic periodontal disease on the background of metabolic syndrome and type 2 diabetes. A correlation analysis between the degree of methylated DNA of the IL6 and MMP13 genes, as well as the content of IL6 and MMP13 in the oral liquid of patients with chronic generalized periodontitis, showed a high positive relationship between these cytokines associated with the degree of chronic periodontitis. Hypomethylation of IL6 and MMP13 gene promoters in patients with chronic periodontitis on the background of metabolic syndrome and type 2 diabetes mellitus leads to an activation of these genes, increased synthesis of proinflammatory cytokine IL6 and metalloproteinase MMP13, which leads to tissue destruction in the focus of inflammation and aggravation of periodontitis.

References

Gross A.J. Periodontitis: a global disease and the primary care provider's role / A.J. Gross, K.T. Paskett, V.J. Cheever, M.S. Lipsky // Postgrad Med J. - 2017. Vol. 93(1103). . 560-565.

Crotti T.N. Osteoimmunology: major and costimulatory pathway expression associated with chronic inflammatory induced bone loss / T.N. Crotti, AASSK. Dharmapatni, E. Alias, D.R. Haynes // J Immunol Res. 2015. . 1-13.

Dandona P. Inflammation: the link between insulin resistance, obesity and diabetes / P. Dandona, A. Aljada, A. Bandyopadhyay // Trends Immunol. 2004. . 4-7.

Feinberg A. P. Epigenetics at the epicenter of modern medicine / A. P. Feinberg // JAMA. 2008. P. 1345- 1350.

Smolen J.S. Interleukin-6: a new therapeutic target / J.S. Smolen, R.N. Maini // Arthritis Res. Ther. 2006. . 407.

Cytokine responses of human gingival fibroblasts to Actinobacillus actinomycetemcomitans cytolethal distending toxin / G.N. Belibasakis, A. Johansson, Y. Wang [et al.] // Cytokine. 2005. . 56-63.

Yoshitake F. Interleukin-6 directly inhibits osteoclast differentiation by suppressing receptor activator of NF-kappaB signaling pathways / F. Yoshitake, S. Itoh, H. Narita, K. Ishihara // J Biol Chem. 2008. Vol.25. 283(17). .11535-40.

Methylation status of a single CpG site in the IL6 promoter is related to IL6 messenger RNA levels and rheumatoid arthritis / C. J. Nile, R.C. Read, M. Akil [et al.] // Arthritis Rheum. 2008. 58(9). . 2686-93.

Increased methylation of interleukin 6 gene is associated with obesity in Korean women / Y.K. Na, H.S. Hong, W.K. Lee [et al.] // Mol Cells. 2015. 38(5). . 452-6.

Moilanen M. Tumor-associated trypsinogen-2 (trypsinogen-2) activates procollagenases (MMP-1,-8,-13) and stromelysin-1 (MMP-3) and degrades type I collagen / M. Moilanen, T. Sorsa, M. Stenman, P. Nyberg // Biochemistry. 2003. V. 42. N. 18. P. 5414-5420.

MMP-13 and TIMP-1 determinations in progressive chronic periodontitis / M. , B. , J.M. Tejerina [et al.] // J Clin Periodontol. 2007. . 729-735.

Hopps E. Matrix metalloproteinases in metabolic syndrome / E. Hopps, G. Caimi // Eur J Intern Med. 2012. 23(2). . 99-104.

Iliopoulos D. Epigenetic regulation of leptin affects MMP-13 expression in osteoarthritic chondrocytes: possible molecular target for osteoarthritis therapeutic intervention / D. Iliopoulos, K.N. Malizos, A. Tsezou //Annals of the rheumatic deseases. 2005. V.66. 2. . 23-29.

Chih-Hsin Tang IL-6 Increases MMP-13 Expression and Motility in Human Chondrosarcoma Cells / Chih-Hsin Tang, Cheng-Fong Chen, Wei-Ming Chen. // J Biol Chem. 2011. Vol.1. . 11056-11066.

Expression of MMP-8 and MMP-13 genes in the periodontal ligament during tooth movement in rats / I., Nishimura M. Nishimura, K. Onodera [et. al]. // J Dent Res. 2003. 82(8). . 646-51.

Published

2020-12-28

How to Cite

Рожко, П. Д., Деньга, О. В., Вербицкая, Т. Г., Шнайдер, С. А., & Бубнов, В. В. (2020). METHYLING OF IL6 AND MMP13 GENE PROMOTORS IN PATIENTS WITH METABOLIC SYNDROME AND TYPE 2 DIABETES ON THE BACKGROUND OF CHRONIC PERIODONTITIS. Innovation in Stomatology, (1), 59–66. https://doi.org/10.35220/2523-420X/2020.1.13

Most read articles by the same author(s)

1 2 3 > >>